CLIFF:OTCMKTS
Cordlife Group Ltd
$0.070
0.00%
(0.00) 1 日
3月31日, 12:27:37 GMT-4 · USD
search
すべての記号
1 日
5 日
1 か月
6 か月
年初来
1 年
5 年
最大
| 記号 | 価格 | 変化 | 変化率 |
|---|
insights_autoCLIFF の上位の分析情報を生成しています...
時価総額
4039.63万
平均出来高
72.00
取引量
0.00
52 週高値
$0.17
52 週安値
$0.07
ベータ版
1.19
発行済株式数
2.68億
従業員数
111
ニュース記事
ウェブの情報から
Simply Wall Street
·
47 分前
Ultra Clean Updates Board Leadership As AI Cycle Shapes Capital Choices
Moomoo
·
5 時間前
$ナスダック総合 (.IXIC.US)$ レナルソン・ロルガット
プロフィール
Cordlife Group Limited, is a consumer health company incorporated in May 2001 and a provider of cord blood and cord lining banking services in Asia. Cordlife has been listed on the mainboard of SGX since March 2012.
Cordlife Group owns the largest network of cord blood banks in Asia with full stem cell processing and storage facilities in six markets including Singapore, Hong Kong, India, Indonesia, and the Philippines. Beyond cord blood and cord lining banking, Cordlife offers diagnostics services, particularly for the mother and child segment, including urine-based newborn metabolic screening, non-invasive prenatal testing, paediatric vision screening and family genetic screening services.
Cordlife's stem cell processing and storage facilities in Singapore, Hong Kong, India, Indonesia, the Philippines and Malaysia were accredited by AABB until 2024 when its accreditation was withdrawn.
In November 2023, the Ministry of Health of Singapore revealed that Cordlife Group had exposed cryopreserved cord blood units at suboptimal temperatures, damaging the cord blood units belonging to at least 2,150 clients and rendering them unsuitable for stem cell transplant purposes. Wikipedia
Cordlife Group Ltd について